How CDMOs Can Implement a Modular PAT Strategy
Process analytical technology (PAT) is playing an increasingly important role in the pharmaceutical and biopharmaceutical industries due to regulatory pressure and the push to reduce costs while managing quality. For CDMOs, any investments into PAT technology must be versatile enough to accommodate a variety of products and processes.
By innovating their service offerings, CDMOs can address some of the major challenges their partners face when deciding to outsource their operations, like loss of control or quality management. In this webinar, we will propose a scenario in which a CDMO can double the return on investment in just one year!